Gritstone | search
Click here to view Gritstone news from 60+ newspapers.
Bookmark or Share- Gritstone bio Takes Action to Preserve Value and Strengthen Capital ...Gritstone bio, Inc. (Nasdaq: GRTS) is a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets.
- Career Opportunities - Gritstone bioGritstone provides opportunities to learn and grow in a dynamic and evolving environment. We spark innovation through collaboration with teams of diverse backgrounds. Work with cutting edge science and technologies to take your career to the next level.
- Press Releases - Gritstone bioGritstone bio Takes Action to Preserve Value and Strengthen Capital Structure. October 10, 2024. Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer. September 30, 2024.
- Gritstone bioGritstone’s goal is to develop groundbreaking immunotherapies for cancers and infectious diseases. Our approach focuses on generating a therapeutic immune response in these patients by unleashing the natural power of a patient’s immune system to recognize and destroy tumors or virally infected cells. It is well-established that one ...
- About - Gritstone bioGritstone bio is developing next-generation vaccines for cancer and infectious disease. Gritstone’s approach seeks to generate potent and durable immune responses by leveraging insights into the immune system’s ability to recognize and destroy diseased cells by targeting select antigens.
More
